Zdrowie i gospodarka · 26/09/2018

FDA Releases Revised Draft Guidance for Compounding Facilities to Address Insanitary Conditions

The FDA is releasing a revised draft guidance to help compounding facilities identify and correct insanitary conditions that could lead to contaminated drug products and serious adverse events, including death.